<VariationArchive VariationID="3254768" VariationName="NM_004463.3(FGD1):c.1564dup (p.Arg522fs)" VariationType="Duplication" Accession="VCV003254768" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3413542" VariationID="3254768">
      <GeneList>
        <Gene Symbol="FGD1" FullName="FYVE, RhoGEF and PH domain containing 1" GeneID="2245" HGNC_ID="HGNC:3663" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="54445454" stop="54496234" display_start="54445454" display_stop="54496234" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="54471886" stop="54522598" display_start="54471886" display_stop="54522598" Strand="-" />
          </Location>
          <OMIM>300546</OMIM>
          <Haploinsufficiency last_evaluated="2021-05-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FGD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-05-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FGD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004463.3(FGD1):c.1564dup (p.Arg522fs)</Name>
      <CanonicalSPDI>NC_000023.11:54465522:GGGGG:GGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="54465522" stop="54465523" display_start="54465522" display_stop="54465523" variantLength="1" positionVCF="54465522" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="54491955" stop="54491956" display_start="54491955" display_stop="54491956" variantLength="1" positionVCF="54491955" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>R522fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.54491960dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.54491960dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.54465527dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.54465527dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008054.1" sequenceAccession="NG_008054" sequenceVersion="1" change="g.35644dup">
            <Expression>NG_008054.1:g.35644dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004463.3" sequenceAccession="NM_004463" sequenceVersion="3" change="c.1564dup" MANESelect="true">
            <Expression>NM_004463.3:c.1564dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004454.2" sequenceAccession="NP_004454" sequenceVersion="2" change="p.Arg522fs">
            <Expression>NP_004454.2:p.Arg522fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004463.3(FGD1):c.1564dup (p.Arg522fs) AND Aarskog syndrome" Accession="RCV004594951" Version="1">
        <ClassifiedConditionList TraitSetID="3026">
          <ClassifiedCondition DB="MedGen" ID="C0175701">Aarskog syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3026" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15926" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FGDY</ElementValue>
                <XRef Type="MIM" ID="305400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER</ElementValue>
                <XRef Type="Allelic variant" ID="300546.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300546.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aarskog-Scott syndrome, X-linked</ElementValue>
                <XRef ID="MONDO:0010589" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aarskog syndrome</ElementValue>
                <XRef ID="Aarskog+Syndrome/58" DB="Genetic Alliance" />
                <XRef ID="14921002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aarskog Scott syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aarskog disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AAS</ElementValue>
                <XRef Type="MIM" ID="305400" DB="OMIM" />
              </Symbol>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21654724</ID>
              </Citation>
              <XRef ID="915" DB="Orphanet" />
              <XRef ID="C0175701" DB="MedGen" />
              <XRef ID="MONDO:0010589" DB="MONDO" />
              <XRef Type="MIM" ID="305400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9874046" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_004463_2_FGD1_c_1564dupC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086921" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Aarskog-Scott syndrome and intellectual developmental disorder, X-linked syndromic 16 (MIM#305400). (I) 0109 - This gene is associated with X-linked recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0253 - This variant is hemizygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other variants predicted to cause NMD comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1205 - This variant has been shown to be maternally inherited (tested by an external laboratory). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FGD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_21160</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004463.2:c.1564dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="305400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9874046" TraitType="Disease" MappingType="XRef" MappingValue="305400" MappingRef="OMIM">
        <MedGen CUI="C0175701" Name="Aarskog syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

